Cargando…

LDL cholesterol estimation in patients with the metabolic syndrome

BACKGROUND: The Friedewald formula (LDL-F) for the estimation of low-density lipoprotein (LDL) cholesterol concentrations is the most often used formula in clinical trials and clinical practice. However, much concern has been raised as to whether this formula is applicable in all patient populations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gazi, Irene, Tsimihodimos, Vasilis, Filippatos, Theodosios D, Saougos, Vasilios G, Bairaktari, Eleni T, Tselepis, Alexandros D, Elisaf, Moses
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550231/ https://www.ncbi.nlm.nih.gov/pubmed/16600020 http://dx.doi.org/10.1186/1476-511X-5-8

Ejemplares similares

PCSK9 and carbohydrate metabolism: A double-edged sword
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential Hypertension
por: Rizos, Evangelos C, et al.
Publicado: (2007)

Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes
por: Kostara, Christina E., et al.
Publicado: (2020)

Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes
por: Derdemezis, Christos S., et al.
Publicado: (2011)

Editorial: Secondary Dyslipidemias
por: Elisaf, Moses, et al.
Publicado: (2011)

The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
por: Dimou, Aikaterini, et al.
Publicado: (2022)

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study
por: Filippatos, Theodosios D., et al.
Publicado: (2013)

Effect of Clinical and Laboratory Parameters on HDL Particle Composition
por: Kostara, Christina E., et al.
Publicado: (2023)

Dyslipidemia Associated with Chronic Kidney Disease
por: Tsimihodimos, Vasilis, et al.
Publicado: (2011)

Thiazide–associated hyponatremia in the elderly: what the clinician needs to know
por: Liamis, George, et al.
Publicado: (2016)

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017)

A Study of the Metabolic Pathways Affected by Gestational Diabetes Mellitus: Comparison with Type 2 Diabetes
por: Spanou, Loukia, et al.
Publicado: (2022)

Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
por: Christopoulou, Eliza, et al.
Publicado: (2019)

Non-hemorrhage-related adverse effects of rivaroxaban
por: Christopoulou, Eliza C., et al.
Publicado: (2017)

Hypercalcemia and acute renal failure associated with calcium carbonate consumption in a patient with hypoparathyroidism
por: Mitrogianni, Zoi, et al.
Publicado: (2014)

No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study
por: Florentin, Matilda, et al.
Publicado: (2019)

Hyponatremia in the elderly: challenges and solutions
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes
por: Papakitsou, Ioanna, et al.
Publicado: (2019)

Progressive, Qualitative, and Quantitative Alterations in HDL Lipidome from Healthy Subjects to Patients with Prediabetes and Type 2 Diabetes
por: Kostara, Christina E., et al.
Publicado: (2022)

Lipidomics in non-alcoholic fatty liver disease
por: Kartsoli, Sofia, et al.
Publicado: (2020)

The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F(2a) levels
por: Rizos, Christos V., et al.
Publicado: (2013)

Postprandial decrease in LDL-cholesterol in men with metabolic syndrome
por: Skoczyńska, Anna, et al.
Publicado: (2015)

The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome
por: Makariou, Stefania, et al.
Publicado: (2012)

Korean public and hospital data for estimating LDL-cholesterol
por: Lee, Taesic, et al.
Publicado: (2018)

Comparison of Newly Proposed LDL-Cholesterol Estimation Equations
por: Jeong, Yong Whi, et al.
Publicado: (2023)

Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study
por: Makariou, Stefania E., et al.
Publicado: (2020)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes
por: Bletsa, Evdoxia, et al.
Publicado: (2021)

High-density lipoprotein cholesterol and multiple myeloma: A systematic review and meta-analysis
por: Makris, Anastasios, et al.
Publicado: (2023)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
por: Murtola, Teemu J., et al.
Publicado: (2012)

Characterization of low density lipoprotein receptor (LDLR) gene mutations in Albania
por: Diakou, Maria, et al.
Publicado: (2010)

The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys
por: Sundvall, Jouko, et al.
Publicado: (2011)

Friedewald’s equation for calculating LDL-cholesterol: Is it the time to say “Goodbye” and adopt direct LDL cholesterol methods?
por: Khan, Sikandar Hayat, et al.
Publicado: (2019)

A Review of Time Courses and Predictors of Lipid Changes with Fenofibric Acid-Statin Combination
por: Filippatos, Theodosios D.
Publicado: (2012)

Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation
por: Fan, Jiahua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e45c09k0cunja9dfq33q3fdfkb